Sample was taken from a large mid-Atlantic medical center where there are providers that specialize in diabetes care. Records where audited from a sample of patients in a 2-year time span who had received Vit D supplementation and who had T2DM with A1C >7.5-10. They had to be older than 18, have diagnosis of T2DM and vitamin D level <30ng/ml to enter into the study. After being approved for the study data was collected such as: the type and dose of vitamin D, number of follow up vitamin D tests and the levels. A1c levels were reviewed at baseline, and 5-8 months after initiation of vitamin D therapy. 366 patients met this criterion. “The mean age of the sample was 54.9 years (standard deviation [SD] — 12.3); 56% (n = 205) were women, and 44% were men (n = 161). The majority of subjects (69.7%) were black (n = 255), and 25.1% (n = 92) were white; there was a small number of subjects in other racial/ethnic categories. AH weights obtained during the study period were collected. The mean minimum weight was 213.5 (SD = 59.1), and the mean maximum weight was 226.4 (SD = 61.4). The mean minimum body mass index (BMI) was 33.6 (SD = 8.5), and the mean maximum BMI was 35.7 (SD = 8.8)” There was a significant improvement in patients A1C who were treated with vitamin D, which validates need for continued research. - aa2b-40d9-8dbe-3c5acf19255a%40sessionmgr101 DQ 2
You've reached the end of your free preview.
Want to read both pages?